固定剂量硝酸异山梨酯-肼屈嗪：基于种族的心血管药物益处还是幻影？
Fixed-dose isosorbide dinitrate-hydralazine: race-based cardiovascular medicine benefit or mirage?
作者信息
Ferdinand Keith C
机构信息
Cardiology Division, Emory University, USA.
出版信息
J Law Med Ethics. 2008 Fall;36(3):458-63. doi: 10.1111/j.1748-720X.2008.291.x.
Abstract
Race is not a scientific category, but African Americans have increased prevalence and severity of heart failure. The African American Heart Failure trial showed the benefit of a combination of isosorbide dinitrate (a nitric oxide donor) and hydralazine (an antioxidant). Future research may unmask the reason for cardiovascular differences in therapy.
摘要
种族并非一个科学范畴，但非裔美国人心力衰竭的患病率和严重程度有所增加。非裔美国人心力衰竭试验表明了硝酸异山梨酯（一种一氧化氮供体）和肼屈嗪（一种抗氧化剂）联合使用的益处。未来的研究可能会揭示心血管治疗差异的原因。
Zotero 插件